Takeda Pharmaceutical Co. Ltd. is shedding dozens of products and an undisclosed number of employees in a $200 million deal. But the Japanese drugmaker is reviving plans to occupy Cambridge’s iconic Genzyme building.
Redline Boston
News about Boston
News about Boston
Takeda Pharmaceutical Co. Ltd. is shedding dozens of products and an undisclosed number of employees in a $200 million deal. But the Japanese drugmaker is reviving plans to occupy Cambridge’s iconic Genzyme building.